158 related articles for article (PubMed ID: 12825097)
1. Tolerability and safety of apomorphine SL (Ixense (TM) ).
Montorsi F
Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
[TBL] [Abstract][Full Text] [Related]
2. Evaluating dose regimens of apomorphine, an open-label study.
Kongkanand A; Opanuraks J; Tantiwongse K; Choeypunt N; Tantiwong A; Amornvejsukit T
Int J Impot Res; 2003 Apr; 15 Suppl 2():S10-2. PubMed ID: 12825098
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of apomorphine SL (Uprima).
Bukofzer S; Livesey N
Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
[TBL] [Abstract][Full Text] [Related]
4. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
Heaton JP
Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
[TBL] [Abstract][Full Text] [Related]
5. A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction.
Von Keitz AT; Ströberg P; Bukofzer S; Mallard N; Hibberd M
BJU Int; 2002 Mar; 89(4):409-15. PubMed ID: 11872034
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
[TBL] [Abstract][Full Text] [Related]
7. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
[TBL] [Abstract][Full Text] [Related]
8. Multidimensional nature of apomorphine SL (Ixense) therapy.
Costa P
Int J Impot Res; 2003 Apr; 15 Suppl 2():S13-5. PubMed ID: 12825099
[TBL] [Abstract][Full Text] [Related]
9. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction.
Mulhall JP; Bukofzer S; Edmonds AL; George M;
Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862
[TBL] [Abstract][Full Text] [Related]
10. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
Perimenis P; Gyftopoulos K; Giannitsas K; Markou SA; Tsota I; Chrysanthopoulou A; Athanasopoulos A; Barbalias G
Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction.
Dula E; Bukofzer S; Perdok R; George M;
Eur Urol; 2001 May; 39(5):558-3; discussion 564. PubMed ID: 11464037
[TBL] [Abstract][Full Text] [Related]
12. Oral treatment of erectile dysfunction with apomorphine SL.
Altwein JE; Keuler FU
Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126
[TBL] [Abstract][Full Text] [Related]
13. Inhalation device allows novel administration of apomorphine in men with erectile dysfunction-efficacy and safety findings.
Riley A; Main M; Morgan F
J Sex Med; 2010 Apr; 7(4 Pt 1):1508-17. PubMed ID: 19845547
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group.
Dula E; Keating W; Siami PF; Edmonds A; O'neil J; Buttler S
Urology; 2000 Jul; 56(1):130-5. PubMed ID: 10869641
[TBL] [Abstract][Full Text] [Related]
15. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
[TBL] [Abstract][Full Text] [Related]
16. Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction.
Maclennan KM; Boshier A; Wilton LV; Shakir SA
BJU Int; 2006 Jul; 98(1):125-31. PubMed ID: 16831156
[TBL] [Abstract][Full Text] [Related]
17. [Apomorphine and erectile dysfunction].
Tan DQ; Yao Y; Zhang J
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
[TBL] [Abstract][Full Text] [Related]
18. Apomorphine SL (Uprima): a new treatment for the management of erectile dysfunction.
Wagner G
Int J Impot Res; 2001 Aug; 13 Suppl 3():S1-2. PubMed ID: 11477485
[No Abstract] [Full Text] [Related]
19. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
20. Emerging oral drugs for erectile dysfunction.
Briganti A; Salonia A; Gallina A; Suardi N; Rigatti P; Montorsi F
Expert Opin Emerg Drugs; 2004 May; 9(1):179-89. PubMed ID: 15155143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
